Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSulfur burps on Wegovy are a recognised gastrointestinal side effect of semaglutide. They occur because the medicine slows how quickly food leaves the stomach, allowing digestive gases (including hydrogen sulphide) to build up and be released as burps with a rotten-egg smell. The NHS medicines page for semaglutide lists burping and indigestion among the common side effects reported during treatment. These burps are unpleasant but not usually a sign that something is medically wrong; they tend to cluster around dose increases and often settle with time and some straightforward dietary adjustments. That said, if you're experiencing them alongside severe stomach pain, it is always worth speaking to your prescriber promptly.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The STEP 1 trial, published in the New England Journal of Medicine, enrolled 1,961 adults with obesity over 68 weeks and recorded gastrointestinal side effects in the majority of participants on semaglutide 2.4 mg. Nausea, diarrhoea, vomiting and constipation received most of the attention, but burping and indigestion were also captured, and clinically, they share the same root cause.
Semaglutide is a GLP-1 receptor agonist. One of its core actions is slowing gastric emptying: the rate at which the stomach pushes food into the small intestine drops considerably. That slower transit time is part of why appetite falls on Wegovy, the stomach stays fuller for longer. The side effect of that mechanism is that food ferments in the stomach for an extended period before moving on. Gut bacteria act on undigested sulphur-containing compounds during that extended window, producing hydrogen sulphide gas. When that gas is expelled upward, the result is the characteristic rotten-egg burp, and understanding what causes sulphur burps on Wegovy comes down to exactly this sequence of events.
This is not unique to Wegovy among GLP-1 medicines (the same pattern is seen across semaglutide formulations) but it is the delayed-gastric-emptying effect that makes it mechanistically predictable rather than incidental.
A question our prescribers hear most weeks: "Is there anything I ate that made this worse?" Almost always, the answer is yes. Foods naturally high in sulphur compounds produce more hydrogen sulphide during digestion, and on Wegovy, that digestion is simply happening more slowly. The biggest triggers are eggs (particularly the yolk), alliums such as onions and garlic, cruciferous vegetables including broccoli, cauliflower and cabbage, and processed meats. Alcohol and fizzy drinks can compound the problem by introducing additional gas and irritating an already-sensitive gut.
None of these foods need to be permanently avoided. The practical approach most people find useful is to reduce portion sizes of high-sulphur foods during the first few weeks of treatment or after a dose increase, eat smaller meals overall, and chew thoroughly to reduce the fermentation load reaching the stomach. Spacing meals further apart (rather than grazing) can also help, since it gives the slower stomach a better chance to empty between sessions.
Staying well hydrated supports gut motility. Fibre from lower-sulphur sources, such as oats and root vegetables, tends to be better tolerated than the fibrous outer leaves of brassicas. For more practical detail on the broader side-effect profile of Wegovy, including how the gastrointestinal effects typically evolve, the NHS guidance is a useful reference point.
If you are wondering whether Wegovy can cause sulfur burps, the short answer is yes, though sulfur burps alone are uncomfortable, not dangerous. The situation changes if they arrive alongside other symptoms. In January 2026, the MHRA issued a Drug Safety Update for GLP-1 medicines drawing specific attention to acute pancreatitis: a serious but infrequent complication that can present as severe, persistent stomach pain spreading toward the back, sometimes with vomiting. If sulfur burps are part of a picture that includes that kind of pain, seek medical help the same day rather than waiting to see whether it passes.
Gallbladder problems (another recognised association with GLP-1 treatment) can also produce upper abdominal discomfort and digestive symptoms. Persistent, worsening pain in the upper right abdomen, especially after eating, is worth reporting to a prescriber rather than attributing to ordinary indigestion. Dehydration is a practical concern if nausea and vomiting accompany the burps; small, frequent sips of water and electrolyte drinks help in the short term, but prolonged vomiting requires clinical input.
Suspected side effects from any medicine can be reported directly to the MHRA through the Yellow Card scheme, and doing so helps build the post-marketing safety picture for medicines under active monitoring. Wegovy carries a Black Triangle designation, meaning the MHRA actively encourages reporting of any side effects, however minor they seem.
For most people, sulfur burps are at their worst in the first two to four weeks of a new dose. The gut is adjusting to a significantly different rate of emptying, and the bacterial ecosystem in the stomach and intestine shifts in response. As that adjustment settles, burping typically becomes less frequent and less pungent. There are practical steps that help manage burps during treatment, and most people find they don't need to stop treatment because of them.
The picture varies, though. People who titrate to higher doses (semaglutide 2.4 mg or, more recently, the 7.2 mg dose approved by the MHRA in April 2026) may notice a recurrence of GI symptoms each time the dose steps up, because the gastric-emptying effect intensifies. That is expected rather than alarming, and it underlines why titration is done gradually under prescriber supervision rather than jumping straight to a maintenance dose.
If burps persist well beyond the adjustment window, or if they are severe enough to affect quality of life, a prescriber can review whether the titration pace suits you individually. Suitability, pace and response to treatment are the kinds of decisions that belong in a clinical conversation, not a food forum. If you are considering starting Wegovy for weight management or want to understand whether it fits your situation, checking your eligibility through a free consultation is the right first step. Our clinical team at nume reviews every consultation personally, the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.